Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Objective of this study is to compare the efficacy and safety between combination ofcolistin and meropenem and combination of amikacin and meropenem for multi‐drug‐resistantgram‐negative bacteria in Intensive Care Unit. In Beni‐ Suef University Hospital.
Epistemonikos ID: 27e2d6f9f9122d2f9f591da4305f066c828af1db
First added on: Jul 11, 2026